From March 11, 2024 to March 31, 2024, the company has repurchased 611,267 shares, representing 0.15% for CNY 17.01 million. With this, the company has completed the repurchase of 611,267 shares, representing 0.15% for CNY 17.01 million under the buyback announced on March 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.95 CNY | -2.52% | -4.35% | -20.18% |
05-20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
04-29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.18% | 1.48B | |
+0.82% | 93.19B | |
0.00% | 39.62B | |
-10.35% | 33.78B | |
+64.64% | 26.82B | |
-16.15% | 15.35B | |
-6.98% | 13.13B | |
-11.77% | 11.6B | |
-49.19% | 10.26B | |
+8.09% | 9.43B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.